228 related articles for article (PubMed ID: 34492262)
1. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract][Full Text] [Related]
2. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
4. Electrosprayed chitosan-coated alginate-pectin beads as potential system for colon-targeted delivery of ellagic acid.
Karakas CY; Ordu HR; Bozkurt F; Karadag A
J Sci Food Agric; 2022 Feb; 102(3):965-975. PubMed ID: 34302363
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
7. Formulated chitosan-sodium tripolyphosphate nanoparticles for co-encapsulation of ellagic acid and anti-inflammatory peptide: characterization, stability and anti-inflammatory activity.
Xiong Y; Feng YX; Chang M; Wang Q; Yin SN; Jian LY; Ren DF
J Sci Food Agric; 2023 May; 103(7):3447-3456. PubMed ID: 36812130
[TBL] [Abstract][Full Text] [Related]
8. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Yang H; Tang C; Yin C
Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid encapsulated chitosan nanoparticles as anti-hemorrhagic agent.
Gopalakrishnan L; Ramana LN; Sethuraman S; Krishnan UM
Carbohydr Polym; 2014 Oct; 111():215-21. PubMed ID: 25037345
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on schizophyllan and chitin nanoparticles for ellagic acid delivery in treating breast cancer.
Pirzadeh-Naeeni S; Mozdianfard MR; Shojaosadati SA; Khorasani AC; Saleh T
Int J Biol Macromol; 2020 Feb; 144():380-388. PubMed ID: 31837368
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-Ellagic Acid Nanohybrid for Mitigating Rotenone-induced Oxidative Stress.
Ahlawat J; Neupane R; Deemer E; Sreenivasan ST; Narayan M
ACS Appl Mater Interfaces; 2020 Apr; 12(16):18964-18977. PubMed ID: 32216327
[TBL] [Abstract][Full Text] [Related]
12. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
13. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer.
Kim S; Nishimoto SK; Bumgardner JD; Haggard WO; Gaber MW; Yang Y
Biomaterials; 2010 May; 31(14):4157-66. PubMed ID: 20185170
[TBL] [Abstract][Full Text] [Related]
14. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo.
Beshbishy AM; Batiha GE; Yokoyama N; Igarashi I
Parasit Vectors; 2019 May; 12(1):269. PubMed ID: 31138282
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
18. Functionalized graphene oxide as nanocarrier for loading and delivery of ellagic Acid.
Kakran M; Sahoo NG; Bao H; Pan Y; Li L
Curr Med Chem; 2011; 18(29):4503-12. PubMed ID: 21864287
[TBL] [Abstract][Full Text] [Related]
19. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer.
Patel G; Yadav BKN
Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881
[TBL] [Abstract][Full Text] [Related]
20. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines.
Nayak D; Minz AP; Ashe S; Rauta PR; Kumari M; Chopra P; Nayak B
J Colloid Interface Sci; 2016 May; 470():142-152. PubMed ID: 26939078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
